Evidence map›Paper›PMID 42122963›Full record

ArticleJournal of clinical medicine2026

Prognostic Significance of Skin Toxicity in Patients with Ras Wild-Type Metastatic Colorectal Cancer Treated with Anti-Egfr Monoclonal Antibodies.

Ridvan Gonul, Oktay Bozkurt, Gozde Erturk Zararsiz, Bugra Umut Kaya, Ahmet Kursat Disli, Ugur Turkmen, Ayse Nuransoy Cengiz, Muhammet Cengiz, Kamuran Yuceer, Mevlude Inanc and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ridvan GonulDepartment of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.ORCID 0009-0000-6494-9088
Oktay BozkurtDepartment of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.ORCID 0000-0003-3551-5234
Gozde Erturk ZararsizDepartment of Biostatistics, School of Medicine, Erciyes University, 38039 Kayseri, Turkey.ORCID 0000-0002-5495-7540
Bugra Umut KayaDepartment of Internal Medicine, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.ORCID 0009-0005-4014-7474
Ahmet Kursat DisliDepartment of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.ORCID 0000-0001-8014-4140
Ugur TurkmenDepartment of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.ORCID 0000-0002-9759-7290
Ayse Nuransoy CengizDepartment of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.
Muhammet CengizDepartment of Medical Oncology, Kayseri City Hospital, 38080 Kayseri, Turkey.
Kamuran YuceerDepartment of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.ORCID 0000-0002-7721-5646
Mevlude InancDepartment of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.
Metin OzkanDepartment of Medical Oncology, Faculty of Medicine, Erciyes University, 38039 Kayseri, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-EGFR monoclonal antibodiesmetastatic colorectal cancerprognosisRAS wild-typeskin toxicity

Identifiers

PMID42122963
PMCPMC13163409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.